OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Chemotherapy is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Ceftobiprole and daptomycin concentrations in valve tissue in a patient with mitralic native valve endocarditis	32
Clinical evaluation of camrelizumab combined with transarterial chemoembolization in the interventional therapy of hepatocellular carcinoma with liver cirrhosis	28
Piperacillin/Tazobactam is associated with a higher risk of acute kidney injury compared to cefepime and meropenem	26
Comparative effectiveness of chemotherapy in different histological types of pancreatic cancer: a PSM-based study using the SEER database	23
Comparative in vitro activities of eravacycline in combination with colistin, meropenem, or ceftazidime against various Achromobacter spp. strains isolated from patients with cystic fibrosis	18
Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant Klebsiella pneumoniae	17
Looking for Stenotrophomonas maltophilia treatment: in vitro activity of ceftazidime/avibactam alone and in combination with aztreonam	16
MiR-302a-3p reduces cisplatin resistance of esophageal squamous cell carcinoma cells by targeting EphA2	14
Underutilisation of prophylactic G-CSF in breast cancer patients receiving adjuvant docetaxel/cyclophosphamide chemotherapy	13
Nivolumab-induced Lambert-Eaton myasthenic syndrome: an immune-related adverse event in nonsmall cell lung cancer	13
YAP/TAZ axis was involved in the effects of metformin on breast cancer	11
Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients	11
Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer	11
The use of antiviral drugs in children	11
Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma	10
The pharmacokinetics of ganciclovir during prolonged intermittent kidney replacement therapy in a cardiac transplant recipient	10
Reevaluating immunotherapy’s potential in first-line metastatic urothelial carcinoma	10
Combination therapy of sotorasib and docetaxel overcomes resistance to sotorasib alone in KRAS G12C mutant lung adenocarcinoma	10
Reversible chemoresistance of pancreatic cancer grown as spheroids	10
Optimization of the vancomycin administration regimen by clinical pharmacists based on a population pharmacokinetics model: a prospective interventional study	10
Causative agents of bloodstream infections in two Croatian hospitals and their resistance mechanisms	10
Activity of ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, cefiderocol and comparators against Gram-negative organisms causing bloodstream infections in Northern Italy (2019–202	9
Identification of chemoresistance targets in doxorubicin-resistant lung adenocarcinoma cells using LC-MS/MS-based proteomics	9
Relationship between the change in tumour-infiltrating lymphocyte level and residual tumour after neoadjuvant chemotherapy in patients with locally advanced breast cancer	9
Dual targeting Bcl-2 and Bcl-xL augments osteosarcoma response to doxorubicin	9

Importance of daptomycin dosage on the clinical outcome in liver transplant recipients with vancomycin-resistant enterococci infection	9
A cost minimisation analysis comparing oral linezolid and intravenous daptomycin administered via an outpatient parenteral antibiotic therapy programme in patients requiring prolonged antibiotic cours	9
Clinical benefit of PD-1/PD-L1 inhibitors for poor performance status patients with advanced non-small cell lung cancer	8
The relationship between statin administration timing and survival outcomes in patients with cancer receiving immune checkpoint blockade	8
Systematic review and meta-analysis of the predictive power of MTHFR polymorphisms for pemetrexed drug efficacy and toxicity in non-small cell lung cancer patients	7
Early daratumumab-based therapy demonstrates significant effectiveness in patients with relapsed and refractory multiple myeloma: a real-world retrospective investigation	7
Review of real-world experience with lurbinectedin in relapsed/refractory small cell lung cancer	7
Initial trough concentration may be beneficial in preventing linezolid-induced thrombocytopenia	7
Capecitabine-associated enterocolitis: Narrative literature review of a rare adverse event and a case presentation	7
Correlation of gemcitabine sensitization by Chk1 inhibition with p53 status	7
The role of maintenance therapy in the treatment of advanced urothelial cancer: a comprehensive systematic review and network meta-analysis	7
Exploring the role of quercetin on doxorubicin and lapatinib-mediated cellular and mitochondrial responses using in vitro and in silico st	7
Developing new drugs for adult T-cell leukemia/lymphoma by targeting hypoxia: insights from toxicity of MS-275 and its analogs	7
Hypomethylating agents combined with low-dose chemotherapy for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: a real-world clinical experience	7
Impact of clinical pharmacist’s interventions on clinical outcomes in appropriate use of colistin: a prospective pre-post intervention study	6
Initial cumulative area under the blood concentration-time curve of vancomycin is associated with the incidence of acute kidney injury	6
In vitro killing of multidrug/extensively drug-resistant Pseudomonas aeruginosa by fosfomycin alone or in combination with antipseudomonal antibiotics	6
Knockdown of METTL5 inhibits the Myc pathway to downregulate PD-L1 expression and inhibits immune escape of hepatocellular carcinoma cells	6
Examining cardiac toxicity in HER2-positive breast cancer patients using trastuzumab and its influencing factors at Iran Hospital	6
Advances in MUC1 resistance to chemotherapy in pancreatic cancer	6
CircRNA_001895 promotes sunitinib resistance of renal cell carcinoma through regulation of apoptosis and DNA damage repair	5
A Phase 1 study of abemaciclib plus abiraterone in Japanese patients with metastatic castration-resistant prostate cancer	5
Impact of ward pharmacist-led antimicrobial stewardship in intensive care units	5
A case of ICIs-associated arthritis caused by Toripalimab initially presenting as oedema in both lower limbs	5
LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma	5
Erythema multiforme as a rare skin manifestation during pembrolizumab treatment: a case report and literature review	5
Cost-effectiveness analysis of dostarlimab plus chemotherapy versus pembrolizumab plus chemotherapy as first-line treatment of metastatic non-squamous non-small cell lun	5
Triptolide inhibits T-cell acute lymphoblastic leukaemia by affecting aberrant epigenetic events in the Wnt signalling pathway	5
METTL3-mediated m6A modification promotes chemoresistance of intrahepatic cholangiocarcinoma by up-regulating NRF2 to inhibit ferroptosis in cisplatin-resistant cells	5
Emerging role of competing endogenous RNA in lung cancer drug resistance	5
Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review	5
Early 3-day course of remdesivir in vaccinated outpatients with SARS-CoV-2 infection. A success story	5
E2F1-induced transcriptional activation of MAL2 inhibits sunitinib sensitivity and promotes the malignant progression of bladder cancer	5
High dose methotrexate in adult Egyptian patients with hematological malignancies: impact of ABCB1 3435C > T rs1045642 and MTHFR 677C > T rs1801133 polymorphisms on toxicities and delayed elimin	5
Aberrant epigenetic regulation of FZD3 by TET2 is involved in ovarian cancer cell resistance to cisplatin	4
Rapid health technology assessment of the novel endonuclease inhibitor baloxavir for the treatment of influenza	4
Impact of a hospital sepsis management protocol on the selection of empirical antibiotics in infectious disease consultations	4
The tumor microenvironment: shaping cancer progression and treatment response	4
Meta-analysis of the efficacy and adverse effects of acalabrutinib in the management of relapsed/refractory chronic lymphocytic leukemia	4
Antimicrobial dosing recommendations during continuous renal replacement therapy: different databases, different doses	4
Infective endocarditis by Serratia species: a systematic review	4
Class 1, 2 and 3 integrons in clinical Pseudomonas aeruginosa isolated from Tanta University Hospitals, Egypt	4
Neurological toxicities with poly (ADP-ribose) polymerase inhibitors in cancer patients: a systematic review and meta-analysis	4
Combination therapy does not decrease 30-day mortality but increases antibiotic consumption in methicillin-sensitive S. aureus bacteraemia	4
Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes in breast cancer patients: a systematic review study	4
Improving therapeutic resistance: beginning with targeting the tumor microenvironment	4
Clinical outcome and safety profile of metastatic pancreatic cancer patients treated with more than six cycles of nab-paclitaxel plus gemcitabine	4
Successful treatment with oxaliplatin and programmed cell death protein 1 inhibitor in recurrent advanced endometrial carcinoma with mismatch repair defects: a case report and literature review	4
Prognostic implications of response to neoadjuvant chemotherapy in breast cancer subtypes	4
Comparison of Syrian generic ceftriaxone sodium preparations for injection: BHT content and its implications	4

Resveratrol suppresses NSCLC cell growth, invasion and migration by mediating Wnt/β-catenin pathway via downregulating SIX4 and SPHK2	3
Are there differences between ceftolozane/tazobactam and ceftazidime/avibactam in treating patients with complicated abdominal infections? Evidence from clinical trials	3
LncRNA-IQCH-AS1 sensitizes thyroid cancer cells to doxorubicin via modulating the miR-196a-5p/PPP2R1B signalling pathway	3
Varicella zoster virus reactivation reported with isatuximab use	3
Colistin resistance among the Gram-negative nosocomial pathogens in India: a systematic review and meta-analysis	3
Benefit from Almonertinib after Osimertinib treat EGFR 19 exon deletion NSCLC induced Severe rash: a case report	3
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge	3
Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey	3
Case report: hypertrophic osteoarthropathy improves with immune checkpoint inhibitor therapy	3
Clinical features, treatments, and outcomes of atezolizumab-induced diabetes mellitus in cancer patients	3
Time to reconsider moxifloxacin anti-anaerobic activity?	3
Antihyperlipidemic drug rosuvastatin suppressed tumor progression and potentiated chemosensitivity by downregulating CCNA2 in lung adenocarcinoma	3
Implementation of effective strategies to prevent Candida auris transmission in a Quaternary Care Center, Riyadh, Saudi Arabia	3
Circ_0030411 aggravates cisplatin-resistance in non-small cell lung cancer by serving as a miR-495-3p sponge to enhance CCND1 expression	3
Combination of mTOR inhibitor PP242 and AMPK activator metformin exerts enhanced inhibitory effects on colorectal carcinoma cells in vitro by blocking multiple kinase pathways	3
The BioWipe: a non-invasive method to detect intestinal carriage of multi-drug resistant GRAM-negative bacteria	3
In vitro and in vivo comparison of eravacycline- and tigecycline-based combination therapies for tigecycline-resistant Acinetobacter baumannii	3
Are small lymphocytic lymphoma and chronic lymphocytic leukemia the same disease? The unsolved dilemma	3
Clinical value of circulating tumour cells in evaluating the efficacy of continuous hepatic arterial infusion among colorectal cancer patients	3
Assessment of in vitro interactions between delafloxacin and other antimicrobials against multi-drug resistant Pseudomonas aeruginosa strains	3
STAT3 and STAT6 polymorphisms predict the severity of adverse reactions in Chinese NSCLC patients receiving EGFR-TKIs therapy	3
Potential role of genetic polymorphisms in neoadjuvant chemotherapy response in breast cancer	3
Case series of metastatic breast cancer patients with visceral crisis treated with CDK4/6 inhibitors	3
Evaluation of in vitro activity of ceftaroline, ceftobiprole and their combination with trimethoprim/sulfamethoxazole against MRSA isolates: a two center study	3
Prognostic and immunological values of SKA3 for overall survival in lung adenocarcinoma and its RNA binding protein involved mechanisms	3
In vitro activity of newer β-lactam/β-lactamase inhibitor combinations, cefiderocol, plazomicin and comparators against carbapenemase-producing Klebsiella pneumoniae<	3
Anti-programmed death ligand 1 immunotherapy in patients with limited-stage small cell lung cancer: a real-world exploratory study	3